✦ LIBER ✦

FIVE YEAR CLINICAL RESULTS FROM ENDEAVOR III: A RANDOMIZED COMPARISON OF THE ZOTAROLIMUS-ELUTING VERSUS SIROLIMUS-ELUTING STENTS IN DE NOVO NATIVE CORONARY LESIONS

✍ Scribed by Kandzari, David E.; Mauri, Laura; Popma, Jeffrey; Turco, Mark A.; O'Shaunessy, Charles; Gurbel, Paul A.; Fitzgerald, Peter J.; Leon, Martin B.

Book ID: 122105795
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 73 KB
Volume: 55
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(10)61807-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized Comparison of the Endeavor

A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions: 12-Month Outcomes From the ENDEAVOR IV Trial

✍ Martin B. Leon; Laura Mauri; Jeffrey J. Popma; Donald E. Cutlip; Eugenia Nikolsk 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 923 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

Two-Year Outcomes After Sirolimus-Elutin

Two-Year Outcomes After Sirolimus-Eluting Stent Implantation: Results From the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) Trial

✍ Giora Weisz; Martin B. Leon; David R. Holmes Jr; Dean J. Kereiakes; Mel R. Clark 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB

The clinical evaluation of the Endeavor

The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study

✍ Shigeru Saito; Ross Prpic; Jeffery J. Popma; John Alexander; Mitchell W. Krucoff 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Comparison of Zotarolimus-Eluting Stent

Comparison of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent for De Novo Coronary Artery DisEase in Patients With DIABETES Mellitus from the ESSENCE-DIABETES II Trial

✍ Park, Gyung-Min; Lee, Seung-Whan; Park, Seong-Wook; Kim, Young-Hak; Yun, Sung-Ch 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 205 KB